Ohcanbohtosat - Sherry Pierce

Aiddostahte ozu
  1. 1
    The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia

    The value of high-dose systemic chemotherapy and intrathecal therapy for central nervous system prophylaxis in different risk groups of adult acute lymphoblastic leukemia Dahkki Jorge E. Cortés, SM O'Brien, Sherry Pierce, MJ Keating, EJ Freireich, HM Kantarjian

    Almmustuhtton 1995
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  2. 2
    Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia

    Results of the hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone regimen in elderly patients with acute lymphocytic leukemia Dahkki Susan O’Brien, Deborah A. Thomas, Farhad Ravandi, Stefan Faderl, Sherry Pierce, Hagop M. Kantarjian

    Almmustuhtton 2008
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  3. 3
    Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemotherapy

    Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia [AML]) on Outcome of AML-Type Chemother... Dahkki Elihu H. Estey, Peter F. Thall, Miloslav Beran, Hagop M. Kantarjian, Sherry Pierce, Michael J. Keating

    Almmustuhtton 1997
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  4. 4
    Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective analysis of survival after long-term follow-up

    Discontinuation of hypomethylating agent therapy in patients with myelodysplastic syndromes or acute myelogenous leukemia in complete remission or partial response: Retrospective a... Dahkki Mónica Cabrero, Elias Jabbour, Farhad Ravandi, Zach Bohannan, Sherry Pierce, Hagop M. Kantarjian, Guillermo Garcia‐Manero

    Almmustuhtton 2015
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  5. 5
    A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter]

    A stratification system for evaluating and selecting therapies in patients with relapsed or primary refractory acute myelogenous leukemia [letter] Dahkki Elihu H. Estey, Steven M. Kornblau, Sherry Pierce, Hagop M. Kantarjian, Miloslav Beran, Michael J. Keating

    Almmustuhtton 1996
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  6. 6
    Comparison of thalidomide and lenalidomide as therapy for myelofibrosis

    Comparison of thalidomide and lenalidomide as therapy for myelofibrosis Dahkki Elias Jabbour, Deborah A. Thomas, Hagop M. Kantarjian, Lingsha Zhou, Sherry Pierce, Jorge E. Cortés, Srđan Verstovšek

    Almmustuhtton 2011
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  7. 7
    Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS)

    Prospective feasibility analysis of reduced-intensity conditioning (RIC) regimens for hematopoietic stem cell transplantation (HSCT) in elderly patients with acute myeloid leukemia... Dahkki Elihu H. Estey, Marcos de Lima, Raoul Tibes, Sherry Pierce, Hagop Kantarjian, Richard E. Champlin, Sergio Giralt

    Almmustuhtton 2006
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  8. 8
    Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience

    Incidence of extramedullary disease in patients with acute promyelocytic leukemia: a single-institution experience Dahkki Arturo Vega-Ruiz, Stefan Faderl, Zeev Estrov, Sherry Pierce, Jorge E. Cortés, Hagop M. Kantarjian, Farhad Ravandi

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  9. 9
    Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia

    Incidence of and risk factors for involvement of the central nervous system in acute myeloid leukemia Dahkki Uri Rozovski, Maro Ohanian, Farhad Ravandi, Guillermo Garcia‐Manero, Stefan Faderl, Sherry Pierce, Jorge E. Cortés, Zeev Estrov

    Almmustuhtton 2014
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  10. 10
    Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia

    Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia Dahkki Alison Gardner, Gloria Mattiuzzi, Stefan Faderl, Gautam Borthakur, Guillermo Garcia‐Manero, Sherry Pierce, Mark Brandt, Elihu H. Estey

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  11. 11
    High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma

    High-grade B-cell lymphomas with TdT expression: a diagnostic and classification dilemma Dahkki Chi Young Ok, L. Jeffrey Medeiros, Beenu Thakral, Guilin Tang, Nitin Jain, Elias Jabbour, Sherry Pierce, Sergej Konoplev

    Almmustuhtton 2018
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  12. 12
    Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia

    Activating internal tandem duplication mutations of the fms-like tyrosine kinase-3 (FLT3-ITD) at complete response and relapse in patients with acute myeloid leukemia Dahkki Aziz Nazha, Jorge E. Cortés, S. Faderl, Sherry Pierce, N. Daver, Tapan Kadia, G. Borthakur, Rajyalakshmi Luthra, Hagop Kantarjian, F. Ravandi

    Almmustuhtton 2012
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  13. 13
    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis

    Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis Dahkki Lucia Masárová, Ahmad Alhuraiji, Prithviraj Bose, Naval Daver, Naveen Pemmaraju, Jorge E. Cortés, Sherry Pierce, Hagop M. Kantarjian, Srđan Verstovšek

    Almmustuhtton 2017
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  14. 14
    EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution experience

    EUTOS score is not predictive for survival and outcome in patients with early chronic phase chronic myeloid leukemia treated with tyrosine kinase inhibitors: a single institution e... Dahkki Elias Jabbour, Jorge E. Cortés, Aziz Nazha, Susan O’Brien, Alfonso Quintás‐Cardama, Sherry Pierce, Guillermo Garcia‐Manero, Hagop M. Kantarjian

    Almmustuhtton 2012
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  15. 15
    Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemia

    Experience with gemtuzumab ozogamycin (“mylotarg”) and all-trans retinoic acid in untreated acute promyelocytic leukemia Dahkki Elihu H. Estey, Francis J. Giles, Miloslav Beran, Susan O’Brien, Sherry Pierce, Stefan Faderl, Jorge E. Cortés, Hagop M. Kantarjian

    Almmustuhtton 2002
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  16. 16
    Outcome of adults with acute lymphocytic leukemia after second salvage therapy

    Outcome of adults with acute lymphocytic leukemia after second salvage therapy Dahkki Susan O’Brien, Deborah Thomas, Farhad Ravandi, Stefan Faderl, Jorge E. Cortés, Gautum Borthakur, Sherry Pierce, Guillermo Garcia‐Manero, Hagop M. Kantarjian

    Almmustuhtton 2008
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  17. 17
    Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment

    Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment Dahkki Roland B. Walter, Megan Othus, Gautam Borthakur, Farhad Ravandi, Jorge E. Cortés, Sherry Pierce, Frederick R. Appelbaum, Hagop Kantarjian, Elihu H. Estey

    Almmustuhtton 2011
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  18. 18
    The incidence and impact of thrombocytopenia in myelodysplastic syndromes

    The incidence and impact of thrombocytopenia in myelodysplastic syndromes Dahkki Hagop M. Kantarjian, Francis J. Giles, Alan F. List, Roger M. Lyons, Mikkael A. Sekeres, Sherry Pierce, Robert Deuson, Joseph A. Leveque

    Almmustuhtton 2007
    Viečča ollesdeavstta Viečča ollesdeavstta
    Revisão
    Lasit oiddohiidda
    Furkejuvvon:
  19. 19
    Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis

    Dynamic Model for Predicting Death Within 12 Months in Patients With Primary or Post–Polycythemia Vera/Essential Thrombocythemia Myelofibrosis Dahkki Constantine S. Tam, Hagop M. Kantarjian, Jorge E. Cortés, Alice Lynn, Sherry Pierce, Lingsha Zhou, Michael J. Keating, Deborah A. Thomas, Srđan Verstovšek

    Almmustuhtton 2009
    Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:
  20. 20
    Lack of Effect of 2-Chlorodeoxyadenosine Therapy in Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine Therapy

    Lack of Effect of 2-Chlorodeoxyadenosine Therapy in Patients with Chronic Lymphocytic Leukemia Refractory to Fludarabine Therapy Dahkki Susan O’Brien, Hagop M. Kantarjian, Elihu H. Estey, Charles Koller, Bud Robertson, Miloslav Beran, Michael Andreeff, Sherry Pierce, Michael J. Keating

    Almmustuhtton 1994
    Viečča ollesdeavstta Viečča ollesdeavstta
    Artigo
    Lasit oiddohiidda
    Furkejuvvon:

Ohcanreaiddut: